Multiply Labs says its robotic clusters cut cost per dose by 74% and lift throughput 100-fold over manual biologics production.
A Zuckerberg-founded nonprofit is assembling $1.8B for open biological AI data, backed by $300M from three tech partners and $500M…
Alphabet's AI drug discovery spinout is back in the market less than five months after a $2.1 billion round.
Nobel laureate Jennifer Doudna's team uses inverse protein folding AI to create never-before-seen genome editing enzymes.